Acetic Anhydride → HCID 54703350, compound
Reaction equation
[CH3:1][O:2][C:3]1[CH:8]=[C:7]([O:9][CH3:10])[CH:6]=[CH:5][C:4]=1[CH:11]1[S:17][CH2:16][CH2:15][N:14]=[C:13]([C:18]2[C:19](=[O:26])[O:20][C:21]([CH3:25])=[CH:22][C:23]=2[OH:24])[CH2:12]1.[BH4-].[Na+].[C:29](OC(=O)C)(=[O:31])[CH3:30].CCN(C(C)C)C(C)C>C(#N)C.O.C(O)C>[C:29]([N:14]1[CH:13]([C:18]2[C:19](=[O:26])[O:20][C:21]([CH3:25])=[CH:22][C:23]=2[OH:24])[CH2:12][CH:11]([C:4]2[CH:5]=[CH:6][C:7]([O:9][CH3:10])=[CH:8][C:3]=2[O:2][CH3:1])[S:17][CH2:16][CH2:15]1)(=[O:31])[CH3:30]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
3-[7-(2,4-Dimethoxyphenyl)-2,3,6,7-tetrahydro-[1,4]thiazepin-5-yl]-4-hydroxy-6-methyl-pyran-2-one (187 mg, 0.5 mmol), prepared as in Reference 5, was combined with absolute ethanol (5 mL) and sodium borohydride (20 mg, 0.526 mmol) and the mixture was warmed on a hot plate to form a solution. The progress of the reaction was followed by analytical HPLC and LCMS and when complete (5 hours) acetic anhydride (1.5 ml. 30 eq) and DIPEA (0.6 mmol, 0.1 mL) were added. The reaction was stirred at room temperature overnight. Product was isolated by preparative HPLC (RPC18 column, acetonitrile/water containing 0.1% HCl) to provide 3-[4-acetyl-7-(2,4-dimethoxy-phenyl)-[1,4]thiazepan-5-yl]-4-hydroxy-6-methyl-pyran-2-one (25 mg). LCMS: MH+ 420.2.
Workup
- temperaturethe mixture was warmed on a hot plate
- customto form a solution
- additionwere added
Sources & evidence
- ORD record
- ord-0220214a1cb04e3b9ce11bb9d8dce149
- Source dataset
- uspto-grants-2005_03
- Patent number
- US06861419B2
Reaction notes
Loading…